WHO treatment guidelines for drug-resistant tuberculosis recommend ART for all HIV positive MDR-TB cases irrespective of CD4 count between two and eight weeks (as early as possible) of starting anti-TB regimen, though the quality of evidence for this recommendation is low.65,66 The optimal timing of ART for HIV associated MDR-TB is still unknown. This evidence concerns the gene CD4 and tuberculosis.